[Adverse effect of biguanides].
Yamasaki
Yoshimitsu
Y
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine.
Kuroda
Akio
A
D000140:Acidosis, Lactic / Q000139:chemically induced; D001645:Biguanides / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D007333:Insulin Resistance; D008687:Metformin / Q000009:adverse effects; D010629:Phenformin / Q000009:adverse effects; D014806:Vitamin B 12 Deficiency / Q000139:chemically induced
D001645:Biguanides; D007004:Hypoglycemic Agents; D008687:Metformin; D010629:Phenformin